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Background: To analyze the longitudinal length accuracy of gross tumor volume (GTV) delineation with diffusion
weighted magnetic resonance imaging for esophageal squamous cell carcinoma (SCC).
Methods: Forty-two patients from December 2011 to June 2012 with esophageal SCC who underwent radical
surgery were analyzed. Routine computed tomography (CT) scan, T2-weighted MRI and diffusion weighted
magnetic resonance imaging (DWI) were employed before surgery. Diffusion-sensitive gradient b-values were taken
at 400, 600, and 800 s/mm2. Gross tumor volumes (GTV) were delineated using CT, T2-weighted MRI and DWI on
different b-value images. GTV longitude length measured using the imaging modalities listed above was compared
with pathologic lesion length to determine the most accurate imaging modality. CMS Xio radiotherapy planning
system was used to fuse DWI scans and CT images to investigate the possibility of delineating GTV on fused
images.
Results: The differences between the GTV length according to CT, T2-weighted MRI and pathology were 3.63 ±
12.06 mm and 3.46 ± 11.41 mm, respectively. When the diffusion-sensitive gradient b-value was 400, 600, and
800 s/mm2, the differences between the GTV length using DWI and pathology were 0.73 ± 6.09 mm, -0.54 ± 6.03 mm
and −1.58 ± 5.71 mm, respectively. DWI scans and CT images were fused accurately using the radiotherapy planning
system. GTV margins were depicted clearly on fused images.
Conclusions: DWI displays esophageal SCC lengths most precisely when compared with CT or regular MRI. DWI scans
fused with CT images can be used to improve accuracy to delineate GTV in esophageal SCC.
Keywords: Esophageal squamous cell carcinoma, Magnetic resonance imaging, Diffusion weighted imaging, Gross
tumor volumeBackground
Accurate delineation of gross target volume (GTV) of
esophageal squamous cell carcinoma (SCC) is an im-
portant step in radiation therapy. Computed tomography
(CT) is the primary modality for delineating GTV and
planning radiation treatment. The transverse section* Correspondence: gao7777@139.com
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reproduction in any medium, provided the ormargin of esophageal SCC GTV is clear on axial CT
scan, while distinguishing the upper and lower margins
of the pathologic esophageal wall using CT is difficult,
the length of the esophageal SCC is often overestimated
when using CT [1]. Although esophagography [2] and
endoscopic ultrasonography can determine GTV length
more accurately than CT, images obtained using these
modalities can’t be fused with CT images in radiotherapy
planning systems because no points on the lesion can be
matched on the images. Some researchers believe that
18 F-fluorodeoxyglucose positron emission tomography. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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geal SCC GTV [3,4]. However, the standardized uptake
value (SUV) threshold of the esophageal SCC must be
ascertained first when 18 F-FDG-PET is employed. As
this threshold value is easily influenced by the patient’s
physiologic state and scanning condition, and SUV
threshold selection criteria vary among different ma-
chines and research centers. A previous study [5] con-
cluded that a SUV cut-off of 2.5 may be used to
delineate the extent of esophageal SCC GTV, but the
conclusion only to use in the research’s hospital because
SUV value can not standardized at different hospital or
different machine at present.
The pathologic lengths and location of esophageal
SCC are important for delineating GTV [6,7]. Therefore,
choosing a more accurate imaging modality to deter-
mine the location and extent of esophageal SCC GTV is
crucial.
Functional magnetic resonance imaging (fMRI) is cur-
rently used to obtain information on tumor biology,
physiology, and molecular level activity. Diffusion-
weighted imaging (DWI), a form of fMRI, can be used to
qualitatively and quantitatively analyze the condition of
water molecules spread inside the organizations, and it
can display microscopic changes such as structural char-
acteristics of pathologic tissues and changes in cell
membrane integrity. DWI has long been used to evalu-
ate intracranial lesions [8]. Since DWI exploits the spe-
cific water diffusion capacity of biological tissue. The
signal intensity depends largely on the presence of bar-
riers to diffusion within the water microenvironment.
The signal intensity is estimated to be higher in viable
tumor tissue with densely packed diffusion-hindering
obstacles than in tissue with less densely packed obsta-
cles, such as tumor necrosis and benign tissue. Based on
this theory, one would expect a difference in signal in-
tensity between benign and malignant disease on DW
images. Currently, DWI is used to distinguish tumor tis-
sue from non-tumor tissue, assess treatment response
and predict treatment outcome. Previous studies have
shown that DWI combined with conventional MRI was
more accurate for staging ovarian cancer than MRI
alone [9,10].
In this prospective study of patients with esophageal
SCC who underwent CT, T2-weighted imaging (T2WI)
and DWI before radical surgery, we sought to measure
the GTV length using these modalities and compare the
length with that measured length using pathology.
Methods
Patients
The imaging and pathologic data for patients with esopha-
geal SCC who underwent transthoracic esophagectomy
with conventional two- or three-field lymphadenectomyperformed by the same experienced surgical team from
December 2011 to June 2012 were prospectively ana-
lyzed. All patients were histopathologically diagnosed
with esophageal SCC before surgery. None of the pa-
tients received preoperative chemotherapy or radio-
therapy. All patients underwent routine pretreatment
evaluations, including physical examination, complete
blood count, biochemistry surveys of liver and kidney
function, electrocardiogram, chest radiography, barium
esophagography, esophagogastroscopy with tumor bi-
opsy, ultrasound evaluation of the neck and abdomen,
and pulmonary function test. Patients with distant me-
tastasis or diabetes mellitus and those who could not
tolerate surgery were excluded. Patients with operable
disease underwent CT and MRI in the same position
with their arms abducted over their heads. Surgical re-
section was deemed suitable for patients with esopha-
geal SCC who had no distant metastasis or definite
direct tumor invasion to adjacent organs on imaging
(T4). Operation was performed within 1–3 days after
the CT and MRI scan. All patients gave written in-
formed consent, and the study was approved by the
Local Research Ethics Committee (Peking University
First Hospital Institutional Ethnic Committee).
CT scan and delineation of GTV
Patients were asked not to eat or drink for 12 hours be-
fore undergoing the plain CT scan, as an empty stomach
is generally required. Patients were positioned supine on
the scanning bed and were asked to hold their breath in
inspiration during the scan. A GE Light Speed Pro32 (GE
Healthcare, Milwaukee, Wisconsin, USA) spiral CT scan-
ner was used with a layer thickness of 5 mm, interlayer
spacing of 5 mm and field of view (FOV) of 36–38 mm,
The scan included the chest entrance of the suprasternal
fossa to the lower edge of the liver. All CT images were
reviewed by the same experienced radiologist and a ra-
diation oncologist. Thickening of the esophageal wall
greater than 5 mm was included in the GTV on CT im-
ages. At the axial level, the longitudinal length of the
GTV was calculated in terms of the number of CT scan-
ning layers.
MR scan and delineation of GTV
Before MR scanning, patients were instructed with the
breath-holding technique. This technique was practiced
to reproduce precisely the same degree of inspiration for
each scan series. MR scanning was performed using a
1.5-T clinical scanner (GE Signa 1.5-T Echo Speed Plus
with EXCITE II) with a maximum gradient strength of
33 mT/m using an eight-tunnel body phased-array coil.
Patients were positioned supine on the scanning bed
throughout the examination. Prior to DWI, T2WI
were obtained in the transverse plane in each patient.
Figure 1 Diagram of the module. A: Structural diagram of the CT
image and MRI scan amalgamation external controlling point
module. B: Cross-sectional diagram of the module.
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images were obtained using the following parameters:
repetition time/echo time, 6R-R interval/72 ms; number
of signals acquired, three; matrix, 320 × 224; field of
view, 36–38 cm; section thickness, 5 mm; gap, 0.5 mm.
DW images were acquired using a single-shot echo-
planar imaging sequence with the array spatial sensitiv-
ity encoding technique (ASSET) in the transverse plane
during breath-holding.
Resolution and signal to noise ratio of DWI images are
determined by the b-values. The formula of b values is
b = γ2G2δ2(Δ-δ/3), where γ represents gyromagnetic ra-
tio; G presents gradient field strength; δ shows the dur-
ation of the gradient field; and Δ represents the time of
two gradient interval. Select a different b-value will have
an impact on DWI imaging. When the b value is high,
the DWI can be more sensitive to water molecules diffu-
sion and can be describe the statues of the water mol-
ecule diffusion more accurately. When b value is small,
the DWI image resolution is high, but T2-shine through,
organ motion, perfusion and other factors can impact
more on the DWI images; these are less sensitive to
water molecule movement. The b values of normal brain
DWI are generally chosen in the range of 800 s/mm2
and 1500 s/mm2, and the b values of body DWI are usu-
ally less than 1000 s/mm2. However, at present there are
no studies on the application to the esophageal carcin-
oma. Based on the former research on body DWI and b-
values they chose, we obtained DWI images with b
values of 0 and 400, 600, 800 s/mm2. The components
of the applied gradients for diffusion weighting were
equal in read, phase, and section orientations to obtain
maximum total gradient strength. Other parameters
were as follows: repetition time/echo time, 2,450 ms/
50.8-67.4 ms; field of view, 44–48 cm; matrix, 128 × 128;
section thickness, 5 mm; gap, 0 mm.
All the MRI scans were reviewed by the same experi-
enced radiologist and a radiation oncologist. Thickening
of the esophageal wall greater than 5 mm was included
in the GTV on T2W images. On DWI scans, high signal
intensity regions were included in the GTV. The length
of the GTV was calculated according to the number of
layers with pathologic changes on T2W images and
DWI images.
Measurement of lesion length using pathologic
specimens
The length of the esophagus was measured in situ before
cutting the esophagus during surgery. Immediately after
the specimen was removed, the esophagus was cut open
along the longitudinal axis. So as to not cut though the
tumor, the esophagus was stretched to the same length
as measured in vivo and pinned on a flat board. Then,
the length of the tumor was measured and recorded.Image fusion
DWI images can not show anatomic structures clearly
due to its spatial resolution is limited, while CT images
can show anatomic structures clearly because of high
spatial resolution. We have to fuse the two images using
treatment planning system and delineate GTV on fused
images. We chose patients with esophageal SCC who
underwent radical radiotherapy to validate the possibility
of fusing DWI scans and CT images. We placed three
modules [11] (Figure 1A) on the body surfaces of the pa-
tients as image match point when they underwent a
planning CT scan using GE Light Speed Pro32 spiral CT
scanner, and T2WI and DWI scanning using a 1.5-T
clinical scanner. The size of the module was 30 mm ×
20 mm × 15 mm. The module included one longitudinal
pipe and one transverse pipe, which were stereo crossed
and mutually perpendicular. The two ends of the longi-
tudinal and transverse pipes were closed and filled with
red liquid for double CT and MRI T2WI development.
The length of the longitudinal pipe was 30 mm, and the
length of the transverse pipe was 20 mm. The inner di-
ameters of the two pipes were 3.5 mm, and the pipe wall
thicknesses were 1.5 mm. The vertical projections of the
longitudinal pipe and transverse pipe are equipped with
relevant longitudinal lines and transverse lines on the
surface crossing point, and the longitudinal lines and
transverse lines are two crossing lines on the mould sur-
face. The mould can show the internal pipe structure
during CT and MRI T2WI scanning. We used the mod-
ule image as the reference point when fusing DWI and
CT scans. During CT scanning, we put the module in
the same position on the body surface as during MRI
T2WI scanning, making the module longitudinal line
parallel with the long axis of the body, and coinciding
the transverse line with the CT and MRI T2WI trans-
verse scanning indicatrices. We used the same thickness
(5 mm) and FOV (40 cm) for CT and MRI scans. All pa-
tients underwent CT and MRI T2WI scanning in the
same position and used a respiratory gating device while
scanning.
On the module middle cross-section, the transverse
pipe on CT images and MRI T2WI scans was the short
line (length 20 mm), whereas the longitudinal pipe on
images was the small dot (the diameter of the dot was
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T2WI scans corresponded to DWI scans on MRI work
station as the DWI image fusing base-level image. After
collecting imaging data, we transferred the images to the
CMS Xio treatment planning system (Version 4.51.02)
(Elekta, Stockholm, Sweden) which can reconstruct
DWI scans and CT images with volume rendering. We
fused base-level DWI scans with base-level CT images
manually, while the other DWI scans and CT images
were fused automatically. Through such procedures we
fused DWI scans with CT images.
Statistical analysis
Statistical analysis was performed using SPSS software
(version 14.0; SPSS, Chicago, Illinois, USA). Paired t-tests
for normally distributed data were used to assess the dif-
ferences between groups. Agreement between DWI GTV
length and pathologic lesion length was assessed using a
Bland-Altman plot. A p value of <0.05 was considered sta-
tistically significant.
Results
We enrolled a total of 42 patients diagnosed with esopha-
geal SCC who underwent CT, T2WI and DWI in the
study. Of these 42 patients, 23 were men and 19 were
women; their ages ranged from 46 to 77 years (median
58.7 years). Of the cases, 12, 20, and 10 were found in the
upper, middle, and lower sections of the chest, respect-
ively. The pathologic types included well-differentiated
SCC (n = 18), moderately differentiated SCC (n = 16), and
poorly differentiated SCC (n = 8). The CT, T2WI, and
DWI scans were complete as were the clinical and patho-
logic data for all the patients.
We considered pathologic lesion length to be the gold
standard for validating the accuracy of tumor delineation
via imaging, and we compared the pathologic specimen
length with the GTV length determined using CT, T2WI
and DWI. The difference between the pathologic lesion
length and GTV length on CT-images and T2WI scans
was 3.63 ± 12.06 mm and 3.46 ± 11.41 mm, respectively
(Table 1). When the diffusion-sensitive gradient b-value
was 400, 600, and 800 s/mm2, the difference between theTable 1 Difference between GTV lengths on scans obtained u
lesion length
Imaging modality GTV length onimages (mm)
Difference value between GTV le
and pathologic lesion length (m
CT 48.91 ± 18.92 3.63 ± 12.06
T2WI 48.75 ± 20.35 3.46 ± 11.41
b = 400 DWI 46.01 ± 17.21 0.73 ± 6.09
b = 600 DWI 44.75 ± 17.48 −0.54 ± 6.03
b = 800 DWI 43.73 ± 17.27 −1.58 ± 5.71
Abbreviation: CT Computed tomography, T2WI T2-weighted imaging b diffusion-senpathologic lesion length and the GTV length on the DWI
scans was 0.73 ± 6.09 mm, -0.54 ± 6.03 mm and −1.58 ±
5.71 mm, respectively.
The difference between the pathologic lesion length
and the GTV length using the various modalities was
not statistically significant (all p>0.05; Table 1).
The Bland-Altman plot displays the relationship be-
tween the pathologic lesion lengths and the GTV lengths
measured using DWI scans. The following figure illus-
trates the high level of agreement between DWI measure-
ments of esophageal SCC GTV lengths and postoperative
pathologic lesion lengths (Figure 2).
We can see from the coronal and sagittal DWI scans
and fused images (Figure 3) that esophageal SCC bound-
ary can be depicted clearly on these images, and that
DWI scans and CT images can fuse well. On CT images
(Figure 4A, I) and T2WI images (Figure 4B, J) the
boundary of the esophageal SCC was not clearly appar-
ent, but DWI scans (Figure 4C, K) and fused images
(Figure 4D, L) can depict the esophageal SCC GTV
upper and lower boundary.
Discussion
The present study investigated different imaging modal-
ities of delineating esophageal SCC GTV for tumor length
determination. Methods tested included CT, T2WI and
DWI scans under different diffusion-sensitive gradient
b-values. We found that the GTV length measured on
DWI scans was close to the pathologic lesion length.
DWI is a non-invasive method for detecting organi-
zational structures at the microscopic level, and mainly
detects structural characteristics of the examined organs
by measuring the diffusion of water molecules. DWI was
first used to diagnose cerebral infarction [12]. Tumors
have high cell density and tumor cells have integral
membranes that limit the movement of water molecules,
thereby contributing to the high signal intensity of le-
sions on DWI scans. DWI scanning is usually performed
at two or more diffusion-sensitive gradient b-values,
which indicates the magnitude and duration of the
applied gradients and the time between the paired gradi-
ents. By varying the amplitudes, lengths and intervalssing various modalities and postoperative pathologic
ngth
m)
p-value of GTV length on images








sitive gradient b value.
Figure 2 Bland-Altman plot between the pathologic lesion lengths and the GTV lengths. A-C: Bland-Altman plot displaying the
relationship between the pathologic lesion lengths and the GTV lengths measured using DWI scans.
Hou et al. Radiation Oncology 2013, 8:169 Page 5 of 7
http://www.ro-journal.com/content/8/1/169among the diffusion gradients, the sensitivity to the de-
gree of diffusion motion can be altered, and the data can
be processed to provide information about actual diffu-
sion distances.
When b-value is high (often>200 s/mm2), DWI is more
sensitive to water molecule diffusion and can depict the
status of water molecule diffusion more accurately than a
low b-value. When b-value is low (often<100 s/mm2),
DWI resolution is high, but T2-shine-through, organ mo-
tion, perfusion and other factors can affect the DWI scans
and render them less sensitive to water molecule move-
ment than a high b-value. The b-values of normal brain
DWI generally range from 800 s/mm2 to 1500 s/mm2,
and the b-values of body DWI are usually less than
1000 s/mm2 [13,14].Figure 3 DWI scans and fused images. A, B and C show the coronal, sag
coronal, sagittal and transverse images of fused images.In our practice, we chose different b-values (400, 600,
and 800 s/mm2) for DWI imaging and delineated GTV
on different b-value DWI images. We measured the
GTV length and compared it with the postoperative spe-
cimen lesion length. Our results showed that GTV on
DWI images has good correlation with pathologic lesion
length. Likewise, the Bland-Altman plot also illustrated a
high level of agreement between DWI measurements of
esophageal tumor lengths and pathologic lengths. Of
note, although the GTV length measured on different b-
value DWI scans correlated with pathologic lesion
length, in the majority of the study cases, a b-value of 600
or 800 s/mm2 DWI images underestimated the GTV
length; this underestimation would lead to inadequate
coverage in delineating GTV. As well, when b-value wasittal and transverse images of DWI scans; D, E and F show the
Figure 4 Different images show the GTV upper boundary, the largest GTV slice and the GTV lower boundary. (A-D) GTV upper boundary
(white arrow) on CT images, T2W images, DWI scans and the fused images; In C and D, the white arrow indicates the upper boundary on DWI
scans and fused images. (E-H) largest GTV slice on images; In E and F, the white arrow indicates the modules on CT image and T2WI image. (I-L)
GTV lower boundary (white arrow) on CT images, T2W images, DWI scans and fused images; In K and L, the white arrow indicates the lower
boundary on DWI scans and fused images.
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14 seconds while scanning, whereas when b-value was
600 s/mm2 and 800 s/mm2, patients needed to hold their
breath for about 18 and 20 seconds, respectively. When b-
value was 400 s/mm2, image resolutions and signal-to-
noise ratios were all satisfactory. Given these factors, we
recommend choosing a b-value of 400 s/mm2 for esopha-
geal SCC DWI scanning; the most suitable b-value for
esophageal SCC research, however, still needs to be deter-
mined via radiology.
DWI scans must be fused with CT images for radio-
therapy planning. We chose patients with esophageal
SCC who underwent radical radiotherapy to validate the
possibility of fusing DWI scans and CT images. We used
imaging fusion software that came with the CMS Xio
treatment planning system to register the DWI scans
and CT images. The radiotherapy planning system can
reconstruct DWI and CT images with volume rendering,
and once we fused base-level DWI scans with base-level
CT images manually, the other DWI scans and CT im-
ages could be fused automatically. Thus, we fused CT
images and DWI scans accurately, and delineated GTVon fused images. The limitation of our study is that the
DWI images can not show anatomic structures clearly due
to its spatial resolution is limit, DWI images have to fuse
with CT images with the help of image match point. So
the precision of image fusing is important. We used
breath-holding technique and hoped through this method,
CT and MRI image quality could be less influenced by the
movement of the body. Another limitation of this study is
lack of lymph nodes assessment through DWI scans be-
cause lymph nodes involvement is also important in radio-
therapy for esophageal cancer. So the accurate diagnosis
of lymph nodes involvement through DWI scans deserves
further study.Conclusions
In summary, our data suggest that DWI scans can depict
esophageal SCC GTV length accurately and also can
show GTV upper and lower margins clearly. At the
same time, DWI scans can be fused with CT images in
radiation treatment planning system, we can use DWI
images delineate GTV on fused images.
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